Sprague John M
CIK 0001730056
Chief Financial Officer
Filings
9
Latest Jan 2, 2025
Issuers covered
1
Showing
9 of 9
Page 1
Track record
3 of 3 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 67% | -1.5% | +19.0% | +25.2% | -48.8% |
| 90 days | 3 | 67% | +27.7% | +71.8% | +78.1% | -66.8% |
| 180 days | 3 | 67% | -6.4% | +14.9% | +45.5% | -79.5% |
| 365 days | 3 | 67% | +57.3% | +91.1% | +91.8% | -10.9% |
Issuers
Companies where Sprague John M has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TTOO | T2 Biosystems, Inc. | 9 | Jan 2, 2025 |
All filings
9 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|